Fibrocell Science Inc (FCSC)

[DewDiligence]

Fifty-six year old Glenda Holman was part of the clinical trial. It's been more than three and a half years since her last injections and she's still seeing improvement. Holman says, “I don't think that it has stopped since the first time I had the treatment done.”

Paradoxically, this could be part of the problem with this product. If changes can still be occurring 3.5 years after the latest injection, it implies that patients getting Laviv commercially (of which there have been virtually none to date) will effectively be participating in an unregulated clinical trial.